Metabolic Modifications by Common Respiratory Viruses and Their Potential as New Antiviral Targets

Jens Kleinehr1, Janine J Wilden1, Yvonne Boergeling1

  • 1Institute of Virology Muenster (IVM), Westfaelische Wilhelms-University Muenster, Von-Esmarch-Str. 56, D-48149 Muenster, Germany.

Viruses
|October 26, 2021
PubMed

Insights

Respiratory viruses alter host cell metabolism, including glycolysis and fatty acid synthesis, for replication. This review explores metabolic changes induced by common respiratory viruses, identifying therapeutic targets.

Area of Science:

  • Virology
  • Cellular Metabolism
  • Infectious Diseases

Background:

  • Respiratory viruses are frequent causes of human lung infections.
  • Viral replication is host-dependent, influencing host cell signaling.
  • Viruses actively induce cellular functions, like metabolic pathways, to benefit replication.

Purpose of the Study:

  • To summarize metabolic pathway modifications induced by acute respiratory viruses.
  • To highlight potential therapeutic targets and compounds for viral infections.

Main Methods:

  • Literature review of studies on respiratory virus-mediated metabolic changes.
  • Focus on respiratory syncytial virus (RSV), rhinovirus (RV), influenza virus (IV), parainfluenza virus (PIV), coronavirus (CoV), and adenovirus (AdV).

Main Results:

  • Respiratory viruses significantly impact host cell metabolic pathways, including glycolysis, fatty acid synthesis (FAS), and the tricarboxylic acid (TCA) cycle.
  • Specific modifications vary depending on the virus.
  • These metabolic alterations are crucial for efficient viral replication.

Conclusions:

  • Understanding virus-induced metabolic reprogramming is key to developing novel antiviral therapies.
  • Targeting these modified metabolic pathways presents a promising therapeutic strategy against respiratory viral infections.

Related Concept Videos

Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
34.9K
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
1.0K
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
229
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
233
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
710
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
20